Hyperuricemia in acute illness: a poor prognostic sign

Area of Science:

• Biochemistry
• Cardiovascular Medicine
• Nephrology

Background:

• Serum urate levels are being investigated as potential biomarkers for severe tissue hypoxia.
• Acute cardiovascular disease presents complex physiological challenges, including potential tissue hypoxia.

Purpose of the Study:

• To evaluate the role of serum urate levels and their changes as a marker for severe tissue hypoxia in patients with acute cardiovascular disease.
• To determine if hyperuricemia can predict a fatal outcome in this patient population.

Main Methods:

• Measured serum urate levels and urine uric acid excretion in 16 patients with acute cardiovascular disease.
• Compared baseline and peak serum urate levels between patients who died and those who survived.
• Assessed factors such as uric acid production and renal excretion, alongside other physiological parameters.

Main Results:

• Patients who died exhibited significantly higher baseline (11.1 mg/dL) and peak (20.7 mg/dL) serum urate levels compared to survivors (6.8 mg/dL and 7.1 mg/dL, respectively).
• Increased uric acid production and decreased renal excretion were noted in non-survivors, potentially linked to impaired renal function.
• Died patients had lower systolic blood pressure, pH, and bicarbonate, with higher heart rate and creatinine levels.

Conclusions:

• Marked hyperuricemia during acute illness may serve as a predictor of a fatal outcome in cardiovascular disease.
• Tissue hypoxia, potentially leading to adenosine triphosphate (ATP) depletion and purine degradation, may contribute to elevated uric acid levels.